Searched for
PHARMA TARIFF IMPACT
Market will be volatile, look for an alternative solution: 5 large-caps from different sectors with upside potential of up to 30%A fall in crude oil prices can trigger a relief rally, which in fact it did in early trade on Thursday. But there is another reality as wel...21 May, 2026, 03.07 PM IST- Smallcaps rally! IIFL Finance, Hindustan Copper, Meesho, other stocks jump up to 7%Smallcap stocks, including IIFL Finance, Meesho, and GRSE, surged up to 7% on Wednesday, outperforming benchmark indices. This rally occurr...13 May, 2026, 11.59 AM IST
- Pharma exports surpass $31 billion in FY26 despite global headwindsIndian pharmaceutical exports reached over $31 billion in FY26. March saw a significant 23% drop, primarily due to a slowdown in the United...05 May, 2026, 12.43 AM IST
- Compliance squeeze, global scrutiny redefine India’s $30 billion pharma export playbookAs global markets prioritise quality and regulatory trust, India’s pharma sector is recalibrating beyond its traditional cost advantage.01 May, 2026, 11.26 AM IST
- Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...29 Apr, 2026, 02.22 PM IST
- India–New Zealand $20 billion FTA: List of sectors set to gain ground as the deal kicks inIndia and New Zealand have signed a Free Trade Agreement. This pact offers zero-duty access for most Indian exports. Key sectors like texti...28 Apr, 2026, 06.46 PM IST
- India–New Zealand sign 'once-in-a-generation' FTAIndia and New Zealand signed a “once-in-a-generation” free trade agreement on Monday that gives New Delhi duty-free access to 100% of tarif...28 Apr, 2026, 01.00 AM IST
- Trump pushes pharma tariffs, but exemptions limit impactThe United States has introduced tariffs on branded drug imports. However, many exemptions will limit their effect. Companies investing in ...06 Apr, 2026, 11.25 PM IST
- Trump tariffs hit patented drugs: Jefferies, Nomura explain impact on pharma stocksThe US has slapped up to 100% tariffs on patented drugs, sparing generics and biosimilars but exposing India’s speciality pharma players. S...06 Apr, 2026, 10.14 AM IST
- India largely shielded from US tariffs on patented drugs due to generic export strength: GTRINew US tariffs on patented drugs will not significantly impact India. The country mainly exports affordable generic medicines to America. T...03 Apr, 2026, 07.15 PM IST
- Pharma calls in sick after Trump’s 100% tariff threatPharma stocks fell Thursday after reports of US President Donald Trump mulling 100% tariffs on imported branded and patented medicine maker...03 Apr, 2026, 08.49 AM IST
- Trump delivers another bitter tariff pill. Who’s set to bite the dust?A new tariff announced by President Trump will impose a 100% levy on patented pharmaceuticals entering the U.S. from October 1, 2025, unles...26 Sep, 2025, 02.59 PM IST
- Sun Pharma, Cipla or Dr Reddy's: Which pharma major is most vulnerable to Trump's 100% tariffPresident Trump's imposition of 100% tariffs on branded drugs has shaken Indian pharma companies, impacting stocks like Sun Pharma, Cipla, ...26 Sep, 2025, 02.00 PM IST
- No chill, just pills! Pharma stocks slide up to 8% as Trump does yes-no-yes on tariffShares of Indian pharma companies, including Aurobindo Pharma, Laurus Labs, IPCA Labs, and Lupin, fell up to 8% after U.S. President Donald...04 Apr, 2025, 02.03 PM IST
- Pharma dodges Trump tariffs in first round but 3 scenarios are likely to haunt future prospectsIndia's pharmaceutical sector avoids immediate impact from newly declared tariffs on over 60 countries. However, HDFC Securities estimates ...03 Apr, 2025, 03.17 PM IST
- Trump’s tariff gambit: 5 Indian sectors on high alert as April 2 deadline loomsAs Trump’s April 2 tariff decision looms, Indian markets brace for potential fallout. Mild tariffs could boost export-driven sectors like p...02 Apr, 2025, 07.35 PM IST
- Generic pain, margin loss: Drug companies may find it hard to adjust with Trump's tariff plansUS President Trump's 25% tariff plan on pharmaceuticals jeopardizes Indian pharma exports, making generics pricier and impacting margins. I...20 Feb, 2025, 12.48 AM IST
Load More
